A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early
- Status
- UNKNOWN
- Phase
- PHASE2
Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
- Status
- COMPLETED
- Phase
- PHASE2
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
TC Avastin. ICORG 08-10, V6
- Status
- COMPLETED
- Phase
- NA
Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
- Status
- COMPLETED
- Phase
- PHASE2